The KEAP1/PGAM5/AIFM1-Mediated oxeiptosis pathway in Alzheimer’s disease
Brain Research · 2024
DOI: 10.1016/j.brainres.2024.149173 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain Research, 2024. Verfasst von Fuxin Zhong und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Hauptthemen laut MEDLINE: Alzheimer Disease, Kelch-Like ECH-Associated Protein 1, Oxidative Stress, Hippocampus. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Chongqing Medical University, Chongqing Municipal Education Commission.
Themen: Demenz
Abstract (Originalsprache)
BACKGROUND: Alzheimer's Disease (AD) is a neurodegenerative disease with mitochondrial dysfunction and oxidative stress. Oxeiptosis is a cell death pathway sensitive to reactive oxygen species (ROS). This study investigates the role of oxeiptosis pathway and mitochondrial damage in AD. METHODS: An AD model was developed in C57BL/6 mice by injecting Aβ1-42 oligomers into the brain. Cognitive function was tested using the Morris water maze. Exposure of HT22 mouse hippocampal neurons to H2O2 induces oxidative stress. Protein levels of KEAP1, PGAM5 and AIFM1 were analyzed by western blot, and mitochondrial damage was observed with electron microscopy. Cell survival rates were using the CCK8 assay and flow cytometry after knocking down KEAP1, PGAM5 and AIFM1. RESULTS: The protein concentrations of KEAP1, PGAM5 and AIFM1 were found to be elevated in the hippocampal tissues of AD mice compared to control group, accompanied by mitochondrial damage in the hippocampal neurons of the AD group. Similarly, in the HT22 oxidative stress model, there was an increase in the protein levels of KEAP1, PGAM5 and AIFM1, along with observed mitochondrial damage. Following individual and combined knockdown of KEAP1, PGAM5 and AIFM1, cell survival rates under oxidative stress conditions were higher compared to H2O2 group, with no significant difference in cell survival rates among the knockdown groups. CONCLUSION: This research underscores the critical role of the KEAP1/PGAM5/AIFM1-mediated oxeiptosis pathway in neuronal cell death, offering insights into potential therapeutic targets for mitigating neurodegeneration in AD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China.
- Institute of Neuroscience, Department of Human Anatomy, Chongqing Medical University, Chongqing 400016, PR China.
- Institute of Neuroscience, Department of Human Anatomy, Chongqing Medical University, Chongqing 400016, PR China. Electronic address: yuweihua@cqmu.edu.cn.
- Department of Geriatrics, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, PR China. Electronic address: yanglyu@hospital.cqmu.edu.cn.
Förderung
- Chongqing Medical University
- Chongqing Municipal Education Commission
Zitieren
APA
Zhong, F., Xiong, L., Wu, J., Chen, Y., Song, J., Yu, W., & Lü, Y. (2024). The KEAP1/PGAM5/AIFM1-Mediated oxeiptosis pathway in Alzheimer’s disease. Brain Research. https://doi.org/10.1016/j.brainres.2024.149173
Vancouver
Zhong F, Xiong L, Wu J, Chen Y, Song J, Yu W, et al. The KEAP1/PGAM5/AIFM1-Mediated oxeiptosis pathway in Alzheimer’s disease. Brain Research. 2024. doi:10.1016/j.brainres.2024.149173
BibTeX
@article{Zhong2024,
author = {Zhong, Fuxin and Xiong, Lei and Wu, Jiani and Chen, Yingxi and Song, Jiaqi and Yu, Weihua and Lü, Yang},
title = {The KEAP1/PGAM5/AIFM1-Mediated oxeiptosis pathway in Alzheimer’s disease},
journal = {Brain Research},
year = {2024},
doi = {10.1016/j.brainres.2024.149173}
}
EUVIMED